NGM·Healthcare·$628M·#396 / 520 in Healthcare
PRME Prime Medicine, Inc.
28HIGH RISK
CATEGORY BREAKDOWN
GROWTH82
QUALITY0
STABILITY10
VALUATION0
GOVERNANCE60
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+55.3%
82
> 50% strong
Gross Margin
Revenue retained after direct costs
N/A
0
> 50% strong
Cash Runway
Months of cash at current burn rate
5 months
8
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
96.3%
13
< 25% strong
Price / Sales
Market cap relative to trailing revenue
135.5x
0
< 3x strong
Rule of 40
Growth rate plus operating margin
-4443
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
23.8%
91
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+37.7%
0
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE PRME WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when PRME's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.